Literature DB >> 24685688

Disease duration and severity impacts on long-term cardiovascular events in Japanese patients with rheumatoid arthritis.

Hiroshi Masuda1, Tetsuro Miyazaki2, Kazunori Shimada1, Naoto Tamura3, Ran Matsudaira3, Takuma Yoshihara1, Hiromichi Ohsaka1, Eiryu Sai1, Rie Matsumori1, Kosuke Fukao1, Makoto Hiki1, Atsumi Kume1, Takashi Kiyanagi1, Yoshinari Takasaki3, Hiroyuki Daida1.   

Abstract

BACKGROUND: Rheumatoid arthritis (RA) increases the mortality and morbidity of cardiovascular disease (CVD). However, the relationship between RA and the risk of CVD in the Japanese population remains unclear. METHODS AND
RESULTS: This study comprised 571 RA patients who were admitted to Juntendo University Hospital from January 1990 to December 2000. Cardiovascular events (CVEs) were defined as cardiac death, acute coronary syndrome (ACS), symptomatic stroke, and congestive heart failure. During follow-up (mean 11.7 ± 5.8 years), 7.5% of the patients died from all causes and 11.0% experienced CVEs. The morbidity of stroke and ACS was 3.6 and 2.5 per 1000 person-years, respectively. The mean RA disease duration at enrolment was significantly longer in patients who experienced CVEs than in those who did not experience CVEs (15.0 ± 12.7 years vs. 10. 8 ± 9.7 years; p = 0.01). Physical disabilities due to RA were more severe in patients who experienced CVEs than in those who did not experience CVEs. Patients with a long RA disease duration showed significantly higher event rates (p = 0.033). Cox proportional hazards analysis identified a longer RA duration as an independent risk factor for CVD (hazard ratio 1.57, 95% CI 1.09-2.30, p = 0.02).
CONCLUSION: Japanese RA patients showed a relatively high incidence of CVD, despite the fact that they had few coronary risk factors. The RA disease duration was an independent risk factor for CVEs.
Copyright © 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Inflammation; Risk factors

Mesh:

Year:  2014        PMID: 24685688     DOI: 10.1016/j.jjcc.2014.02.018

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  12 in total

1.  The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.

Authors:  Elena Myasoedova; Arun Chandran; Birkan Ilhan; Brittny T Major; C John Michet; Eric L Matteson; Cynthia S Crowson
Journal:  Ann Rheum Dis       Date:  2015-01-30       Impact factor: 19.103

Review 2.  Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons From Therapeutic Intervention.

Authors:  Neal S Parikh; Alexander E Merkler; Costantino Iadecola
Journal:  Stroke       Date:  2020-02-12       Impact factor: 7.914

3.  Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?

Authors:  Elena Myasoedova; Sherine E Gabriel; Eric L Matteson; John M Davis; Terry M Therneau; Cynthia S Crowson
Journal:  J Rheumatol       Date:  2017-04-01       Impact factor: 4.666

4.  Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis.

Authors:  Naoki Sugimoto; Ayako Nakajima; Eisuke Inoue; Kumi Shidara; Hiroyuki Yamashita; Akio Mimori; Hitoshi Tokuda; Yohei Seto; Eiichi Tanaka; Shigeki Momohara; Atsuo Taniguchi; Hisashi Yamanaka
Journal:  Rheumatol Int       Date:  2017-09-07       Impact factor: 2.631

5.  Persistence and treatment-free interval in patients being prescribed biological drugs in rheumatology practices in Germany.

Authors:  Karel Kostev; Louis Jacob
Journal:  Eur J Clin Pharmacol       Date:  2019-01-21       Impact factor: 2.953

6.  Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study.

Authors:  Usman Khalid; Alexander Egeberg; Ole Ahlehoff; Deirdre Lane; Gunnar H Gislason; Gregory Y H Lip; Peter R Hansen
Journal:  J Am Heart Assoc       Date:  2018-01-19       Impact factor: 5.501

7.  Duration of psoriatic arthritis as a risk factor for myocardial infarction.

Authors:  Alexander Egeberg; Lone Skov; Peter Riis Hansen; Gunnar H Gislason; Jashin J Wu; Jacob P Thyssen; Lotus Mallbris
Journal:  Rheumatol Adv Pract       Date:  2018-04-05

8.  Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3.

Authors:  Alexis Ogdie; Andrea B Troxel; Nehal N Mehta; Joel M Gelfand
Journal:  J Invest Dermatol       Date:  2015-09       Impact factor: 8.551

9.  Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study.

Authors:  Tsan-Hon Liou; Shih-Wei Huang; Jia-Wei Lin; Yu-Sheng Chang; Chin-Wen Wu; Hui-Wen Lin
Journal:  Sci Rep       Date:  2014-06-05       Impact factor: 4.379

10.  Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study.

Authors:  Sophie J Bernelot Moens; Fleur M van der Valk; Aart C Strang; Jeffrey Kroon; Loek P Smits; Eva L Kneepkens; Hein J Verberne; Jaap D van Buul; Michael T Nurmohamed; Erik S G Stroes
Journal:  Arthritis Res Ther       Date:  2016-05-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.